Indepentednt logo

Monitoring patients on disease-modifying antirheumatic drugs

Dr Nigel Watson describes the action taken by his practice to ensure that all patients on DMARDs are adequately monitored, after audit revealed shortfalls

Published online: 01 June 2000

Log in or register now for FREE in order to:

  • benefit from unlimited access to all pages, including:
    • 180+ guideline summaries
    • 1000+ evidence-based articles
  • review and leave comments on all articles and summaries
  • automatically track your reading and learning via your CPD tracker
  • on-demand webinars presented by leading clinical experts

Registration only takes 2 minutes and it will give you FREE access to all content across:



Need help? Email us